KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Realty Trust (HR) Gains from Investment Securities (2016 - 2025)

Healthcare Realty Trust (HR) has 13 years of Gains from Investment Securities data on record, last reported at $21.4 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 103.81% year-over-year to $21.4 million; the TTM value through Dec 2025 reached $21.5 million, up 104.94%, while the annual FY2025 figure was $21.5 million, 104.94% up from the prior year.
  • Gains from Investment Securities reached $21.4 million in Q4 2025 per HR's latest filing, up from -$10.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $32.8 million in Q2 2021 and bottomed at -$10.7 million in Q3 2025.
  • Average Gains from Investment Securities over 5 years is $4.1 million, with a median of $1.1 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: surged 2717.65% in 2023, then crashed 62747.06% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $32.8 million in 2021, then plummeted by 100.16% to -$51000.0 in 2022, then tumbled by 8427.45% to -$4.3 million in 2023, then skyrocketed by 341.09% to $10.5 million in 2024, then skyrocketed by 103.81% to $21.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $21.4 million in Q4 2025, -$10.7 million in Q3 2025, and $7.3 million in Q2 2025.